Literature DB >> 21223985

Development of a lyophilized plasmid/LPEI polyplex formulation with long-term stability--A step closer from promising technology to application.

Julia Christina Kasper1, David Schaffert, Manfred Ogris, Ernst Wagner, Wolfgang Friess.   

Abstract

Cationic polymer/DNA complexes are limited by their instability in aqueous suspensions and usually have to be freshly prepared prior to administration. Thus, the development of isotonic lyophilized polyplex formulations with long-term stability is a desirable goal. Polyplexes based on 22kDa linear polyethylenimine were prepared using a micro-mixer method. Freeze-thawing and lyophilization were performed on a pilot scale freeze-drier. Several excipients (trehalose, sucrose, lactosucrose, dextran, hydroxypropylbetadex or povidone and combinations thereof) at varying concentrations were evaluated for their stabilizing potential against freezing and dehydration induced stresses. For stability testing the lyophilized samples were stored for 6 weeks at 2-8°C, 20°C and 40°C, respectively. Polyplex samples were characterized for particle size, zeta potential, their in vitro transfection efficiency and metabolic activity in Neuro2A cells. In addition, liquid samples were investigated for turbidity and number of sub-visible particles and solid samples were analyzed for residual moisture content, glass transition temperature and sample morphology. L-histidine buffer pH 6.0 was selected as effective buffer. In isotonic formulations with 14% lactosucrose, 10% hydroxypropylbetadex/6.5% sucrose or 10% povidone/6.3% sucrose, particle size was <170nm for all formulations and did not change after storage for 6weeks at 40°C. Polyplexes formulated with lactosucrose or hydroxypropylbetadex/sucrose showed high transfection efficiencies and cellular metabolic activities. Absence of large aggregates was indicated by turbidity and subvisible particle number measurements. The current standard limits for particulate contamination for small volume parenterals were met for all formulations. All samples were amorphous with low residual moisture levels (<1.3%) and high glass transition temperatures (>90°C).
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21223985     DOI: 10.1016/j.jconrel.2011.01.003

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  15 in total

1.  A proof of concept gene-activated titanium surface for oral implantology applications.

Authors:  Noah Z Laird; Walla I Malkawi; Jaidev L Chakka; Timothy M Acri; Satheesh Elangovan; Aliasger K Salem
Journal:  J Tissue Eng Regen Med       Date:  2020-03-04       Impact factor: 3.963

2.  Optimization of the fine particle fraction of a lyophilized lysozyme formulation for dry powder inhalation.

Authors:  Sarah Claus; Claudius Weiler; Joerg Schiewe; Wolfgang Friess
Journal:  Pharm Res       Date:  2013-04-09       Impact factor: 4.200

Review 3.  siRNA delivery to the lung: what's new?

Authors:  Olivia M Merkel; Israel Rubinstein; Thomas Kissel
Journal:  Adv Drug Deliv Rev       Date:  2014-06-05       Impact factor: 15.470

4.  Excipients for the lyoprotection of MAPKAP kinase 2 inhibitory peptide nano-polyplexes.

Authors:  Alvin J Mukalel; Brian C Evans; Kameron V Kilchrist; Eric A Dailing; Benjamin Burdette; Joyce Cheung-Flynn; Colleen M Brophy; Craig L Duvall
Journal:  J Control Release       Date:  2018-04-27       Impact factor: 9.776

Review 5.  Nanoparticle-based technologies for retinal gene therapy.

Authors:  Jeffrey Adijanto; Muna I Naash
Journal:  Eur J Pharm Biopharm       Date:  2015-01-12       Impact factor: 5.571

6.  Aerosol Delivery of siRNA to the Lungs. Part 2: Nanocarrier-based Delivery Systems.

Authors:  Susanne R Youngren-Ortiz; Nishant S Gandhi; Laura España-Serrano; Mahavir B Chougule
Journal:  Kona       Date:  2016-04-30       Impact factor: 2.897

7.  Poly(trehalose): sugar-coated nanocomplexes promote stabilization and effective polyplex-mediated siRNA delivery.

Authors:  Antons Sizovs; Lian Xue; Zachary P Tolstyka; Nilesh P Ingle; Yaoying Wu; Mallory Cortez; Theresa M Reineke
Journal:  J Am Chem Soc       Date:  2013-10-01       Impact factor: 15.419

8.  Trehalose maintains bioactivity and promotes sustained release of BMP-2 from lyophilized CDHA scaffolds for enhanced osteogenesis in vitro and in vivo.

Authors:  Jun Zhao; Shaoyi Wang; Jianqiang Bao; Xiaojuan Sun; Xiaochen Zhang; Xiuli Zhang; Dongxia Ye; Jie Wei; Changsheng Liu; Xinquan Jiang; Gang Shen; Zhiyuan Zhang
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

9.  Effects of lyoprotectants on long-term stability and transfection efficacy of lyophilized poly(lactide-co-glycolide)-graft-polyethylenimine/plasmid DNA polyplexes.

Authors:  Joshua Woo; Jeoung Soo Lee
Journal:  Nanomedicine (Lond)       Date:  2021-05-28       Impact factor: 5.307

10.  Formulating food protein-stabilized indomethacin nanosuspensions into pellets by fluid-bed coating technology: physical characterization, redispersibility, and dissolution.

Authors:  Wei He; Yi Lu; Jianping Qi; Lingyun Chen; Lifang Yin; Wei Wu
Journal:  Int J Nanomedicine       Date:  2013-08-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.